A Phase I–II Trial of Topotecan and Gemcitabine in Patients with Previously Treated, Advanced Non-small Cell Lung Cancer (LOA-3)

David A. Rinaldi Louisiana Oncology Associates, 501 W. St. Mary Blvd., Suite 200, Lafayette, LA, 70506, U.S.A.

, M.D.,

D. Rinaldi Louisiana Oncology Associates, 501 W. St. Mary Blvd., Suite 200, Lafayette, LA, 70506, U.S.A.

, M.D.,

N. Lormand Louisiana Oncology Associates, 501 W. St. Mary Blvd., Suite 200, Lafayette, LA, 70506, U.S.A.

, C.C.R.P.,

J. Brierre Louisiana Oncology Associates, 501 W. St. Mary Blvd., Suite 200, Lafayette, LA, 70506, U.S.A.

, M.D.,

J. Cole Louisiana Oncology Associates, 501 W. St. Mary Blvd., Suite 200, Lafayette, LA, 70506, U.S.A.

, M.D.,

B. Barnes Louisiana Oncology Associates, 501 W. St. Mary Blvd., Suite 200, Lafayette, LA, 70506, U.S.A.

, M.D.,

F. Fontenot Louisiana Oncology Associates, 501 W. St. Mary Blvd., Suite 200, Lafayette, LA, 70506, U.S.A.

, P.A.-C.,

E. Buller Louisiana Oncology Associates, 501 W. St. Mary Blvd., Suite 200, Lafayette, LA, 70506, U.S.A.

, P.A.-C. &

J. Rainey Louisiana Oncology Associates, 501 W. St. Mary Blvd., Suite 200, Lafayette, LA, 70506, U.S.A.

Articles from other publishers (9)